AGENUS INC
SEC CIK 1098972 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | 10% | 21.77M | $17.49M | — | 10 | 2021-10-19 | 2023-10-12 |
Most active insiders at INKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Barbara | Dir | — | $46.6K |
| 2 | Holcomb John Bradley | Dir | — | — |
| 3 | Kadlec Robert Peter | Dir | — | — |
| 4 | Behner Peter | Dir | — | — |
| 5 | Buell Jennifer | CEO | — | — |
| 6 | Corvese Brian | Dir | — | — |
| 7 | WIINBERG ULF | Dir | — | — |
AGENUS INC made no open-market trades at INKT in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-16 | 2023-10-12+ | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.10 | +23.0K | 21.77M | +0.1% | +$25.3K |
| 2023-10-06 | 2023-10-04 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.09 | +15.0K | 21.75M | +0.1% | +$16.4K | |
| 2023-08-31 | 2023-08-29 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.52 | +29.7K | 21.73M | +0.1% | +$45.1K | |
| M | 2023-08-28 | 2023-08-24+ | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.53 | +183.1K | 21.71M | +0.9% | +$280.7K |
| A | 2023-05-26 | 2023-05-01 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | J - Other | $0.00 | -5.01M | 21.33M | -19% | $0 |
| M | 2023-05-12 | 2023-05-10+ | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.47 | +45.4K | 21.62M | +0.2% | +$66.7K |
| M | 2023-05-05 | 2023-05-03+ | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $1.04 | +250.4K | 21.59M | +1% | +$260.4K |
| 2023-05-03 | 2023-05-01 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | J - Other | $0.00 | -4.99M | 21.34M | -19% | $0 | |
| D | 2021-10-20 | 2021-10-19 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | C - Cnv Deriv | — | -5.45M | 26.33M | -17% | — |
| D | 2021-10-20 | 2021-10-19 | INKT | MiNK Therapeutics, Inc. | AGENUS INC | 10% | P - Purchase | $12.00 | +1.40M | 20.88M | +7% | +$16.80M |
Purchase Sale Sale after option exercise All abbreviations